Early myeloid-derived suppressor cells (HLA-DR


Journal

Journal of hematology & oncology
ISSN: 1756-8722
Titre abrégé: J Hematol Oncol
Pays: England
ID NLM: 101468937

Informations de publication

Date de publication:
18 03 2019
Historique:
received: 21 12 2018
accepted: 21 02 2019
entrez: 20 3 2019
pubmed: 20 3 2019
medline: 16 5 2020
Statut: epublish

Résumé

Myeloid-derived suppressor cells (MDSCs) are proposed to control graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the definition of human MDSCs has not yet reached consensus, and the mechanism of MDSCs to control GVHD remains unclear. Immature myeloid cells (HLA-DR In the present study, G-CSF mobilized HLA-DR HLA-DR

Identifiants

pubmed: 30885244
doi: 10.1186/s13045-019-0710-0
pii: 10.1186/s13045-019-0710-0
pmc: PMC6423891
doi:

Substances chimiques

Granulocyte Colony-Stimulating Factor 143011-72-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

31

Références

Immunotherapy. 2012 Mar;4(3):291-304
pubmed: 22401635
Bone Marrow Transplant. 1995 Jun;15(6):825-8
pubmed: 7581076
Dev Comp Immunol. 2004 May 3;28(5):509-54
pubmed: 15062647
Clin Immunol. 2012 Apr;143(1):83-7
pubmed: 22341087
Blood. 2011 Aug 25;118(8):2254-65
pubmed: 21734236
Annu Rev Pathol. 2017 Jan 24;12:187-215
pubmed: 27959627
Blood. 2018 Jun 14;131(24):2651-2660
pubmed: 29728401
Blood. 1995 Dec 15;86(12):4422-9
pubmed: 8541530
Haematologica. 2004 Dec;89(12):1517-24
pubmed: 15590404
PLoS One. 2015 Jul 15;10(7):e0133216
pubmed: 26176698
N Engl J Med. 2017 Nov 30;377(22):2167-2179
pubmed: 29171820
Blood. 2000 Apr 15;95(8):2484-90
pubmed: 10753825
Transplantation. 1997 Aug 27;64(4):553-8
pubmed: 9293864
J Immunol. 2005 Jan 1;174(1):551-6
pubmed: 15611282
Front Immunol. 2018 Aug 30;9:1943
pubmed: 30214443
Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56
pubmed: 16338616
Leukemia. 2013 Feb;27(2):377-88
pubmed: 22828446
Immunity. 2010 Jun 25;32(6):790-802
pubmed: 20605485
Nat Med. 2003 Sep;9(9):1144-50
pubmed: 12925844
J Immunol. 2003 Aug 1;171(3):1232-9
pubmed: 12874210
J Hematol Oncol. 2018 Jul 31;11(1):97
pubmed: 30064449
Leukemia. 2016 Oct;30(10):2055-2063
pubmed: 27133816
Br J Haematol. 2016 Oct;175(2):265-274
pubmed: 27352174
Oncoimmunology. 2016 Mar 28;5(6):e1146842
pubmed: 27471614
J Immunol. 2010 Aug 15;185(4):2273-84
pubmed: 20644162
Blood. 2003 Jul 15;102(2):734-9
pubmed: 12676791
JAMA. 2010 Apr 28;303(16):1617-24
pubmed: 20424252
Biol Blood Marrow Transplant. 1999;5(6):347-56
pubmed: 10595812
Ann N Y Acad Sci. 2014 Jun;1319:47-65
pubmed: 24965257
Blood. 1998 Jul 1;92(1):215-22
pubmed: 9639519
Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):721s-726s
pubmed: 17255300
Blood. 2015 Aug 27;126(9):1138-48
pubmed: 26185131
Nat Rev Cancer. 2013 Oct;13(10):739-52
pubmed: 24060865
J Hematol Oncol. 2017 Jul 4;10(1):135
pubmed: 28676100
Blood. 1997 Mar 1;89(5):1629-34
pubmed: 9057645
J Immunol. 2015 Jul 15;195(2):717-25
pubmed: 26048147
Biol Blood Marrow Transplant. 2014 Dec;20(12):2049-55
pubmed: 25246295
J Immunol. 1995 Jul 15;155(2):585-93
pubmed: 7608537
J Immunol. 2016 Nov 1;197(9):3725-3734
pubmed: 27707998
Blood. 2015 Jun 18;125(25):3956-62
pubmed: 25940714
Trends Immunol. 2016 Mar;37(3):208-220
pubmed: 26858199
J Hematol Oncol. 2018 Dec 7;11(1):135
pubmed: 30526632
J Immunol. 2005 Feb 15;174(4):1841-50
pubmed: 15699110
J Immunol. 2005 Dec 1;175(11):7085-91
pubmed: 16301609
Nat Commun. 2016 Jul 06;7:12150
pubmed: 27381735
Am J Hematol. 2015 Jan;90(1):E9-E16
pubmed: 25303038
J Immunol. 2001 Jan 1;166(1):678-89
pubmed: 11123353
Expert Rev Clin Immunol. 2015 Apr;11(4):457-65
pubmed: 25748625
Biol Blood Marrow Transplant. 2013 May;19(5):692-702
pubmed: 23376089
Bone Marrow Transplant. 2012 Dec;47(12):1507-12
pubmed: 22635243
Clin Cancer Res. 2016 Jul 15;22(14):3467-76
pubmed: 26927664
Blood. 2012 Jul 26;120(4):905-13
pubmed: 22709687
J Hematol Oncol. 2018 Jan 12;11(1):8
pubmed: 29329556
Cancer Res. 2004 Nov 15;64(22):8451-5
pubmed: 15548717
Nat Rev Immunol. 2012 Mar 22;12(4):253-68
pubmed: 22437938
Trends Immunol. 2011 Jan;32(1):19-25
pubmed: 21067974

Auteurs

Ke Wang (K)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, No.5 Yiheyuan Road, Beijing, 100871, China.

Meng Lv (M)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Ying-Jun Chang (YJ)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Xiang-Yu Zhao (XY)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Xiao-Su Zhao (XS)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Yuan-Yuan Zhang (YY)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Yu-Qian Sun (YQ)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Zhi-Dong Wang (ZD)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Pan Suo (P)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Yang Zhou (Y)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Dan Liu (D)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Shu-Zhen Zhai (SZ)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Yan Hong (Y)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Yu Wang (Y)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Xiao-Hui Zhang (XH)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Lan-Ping Xu (LP)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Kai-Yan Liu (KY)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.

Xiao-Jun Huang (XJ)

Peking University People's Hospital, Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China. xjhrm@medmail.com.cn.
Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, No.5 Yiheyuan Road, Beijing, 100871, China. xjhrm@medmail.com.cn.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH